Wu-Chou Lin

435 total citations
23 papers, 247 citations indexed

About

Wu-Chou Lin is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Wu-Chou Lin has authored 23 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Obstetrics and Gynecology, 11 papers in Reproductive Medicine and 6 papers in Surgery. Recurrent topics in Wu-Chou Lin's work include Endometrial and Cervical Cancer Treatments (8 papers), Endometriosis Research and Treatment (6 papers) and Uterine Myomas and Treatments (5 papers). Wu-Chou Lin is often cited by papers focused on Endometrial and Cervical Cancer Treatments (8 papers), Endometriosis Research and Treatment (6 papers) and Uterine Myomas and Treatments (5 papers). Wu-Chou Lin collaborates with scholars based in Taiwan, Australia and China. Wu-Chou Lin's co-authors include Lei Wan, Jen‐Huai Chiang, Cherry Yin‐Yi Chang, Lian‐Shung Yeh, Shang-Wen Chen, Ji‐An Liang, Yao‐Ching Hung, Wei‐Chun Chang, Hsun‐Ming Chang and Yiyan Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Wu-Chou Lin

21 papers receiving 244 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wu-Chou Lin Taiwan 9 124 120 56 37 31 23 247
Giuseppe Gabriele Iorio Italy 9 63 0.5× 119 1.0× 37 0.7× 13 0.4× 11 0.4× 21 252
Nikolaos Burbos United Kingdom 11 194 1.6× 129 1.1× 12 0.2× 36 1.0× 5 0.2× 30 297
Christiane Ahlers Germany 9 83 0.7× 95 0.8× 14 0.3× 15 0.4× 46 1.5× 17 261
Paolo Maniglio Italy 9 92 0.7× 114 0.9× 14 0.3× 64 1.7× 5 0.2× 15 238
Antonio Mercorio Italy 10 181 1.5× 302 2.5× 42 0.8× 62 1.7× 5 0.2× 30 449
M. Condorelli Italy 9 20 0.2× 88 0.7× 17 0.3× 29 0.8× 37 1.2× 39 268
Berit Gull Sweden 11 537 4.3× 481 4.0× 55 1.0× 16 0.4× 13 0.4× 17 700
Jeffrey Elder United States 6 76 0.6× 113 0.9× 17 0.3× 56 1.5× 6 0.2× 11 224
V. F. Bezhenar Russia 7 107 0.9× 78 0.7× 13 0.2× 21 0.6× 4 0.1× 95 184
Daopeng Yang China 5 30 0.2× 286 2.4× 23 0.4× 28 0.8× 5 0.2× 19 375

Countries citing papers authored by Wu-Chou Lin

Since Specialization
Citations

This map shows the geographic impact of Wu-Chou Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wu-Chou Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wu-Chou Lin more than expected).

Fields of papers citing papers by Wu-Chou Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wu-Chou Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wu-Chou Lin. The network helps show where Wu-Chou Lin may publish in the future.

Co-authorship network of co-authors of Wu-Chou Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Wu-Chou Lin. A scholar is included among the top collaborators of Wu-Chou Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wu-Chou Lin. Wu-Chou Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Hsuan-Ju, Ming-Jer Chen, Po‐Han Chang, et al.. (2025). Regenerative therapies for refractory thin endometrium in in vitro fertilization. Frontiers in Cell and Developmental Biology. 13. 1668960–1668960.
3.
Liang, Ji‐An, Yao‐Ching Hung, Lian‐Shung Yeh, et al.. (2022). Image-guided brachytherapy following external-beam radiation therapy for patients with inoperable endometrial cancer. Brachytherapy. 22(1). 72–79. 2 indexed citations
4.
Chang, Chia‐Wei, et al.. (2022). Growth hormone in fertility and infertility: Mechanisms of action and clinical applications. Frontiers in Endocrinology. 13. 1040503–1040503. 35 indexed citations
5.
Su, Jun-Wei, et al.. (2022). Cervical pregnancy: a case report of hysteroscopic resection and balloon compression combined with systematic methotrexate treatment. Taiwanese Journal of Obstetrics and Gynecology. 61(6). 1061–1064. 4 indexed citations
6.
Huang, Mingcheng, Mao-Feng Sun, Cheng‐Li Lin, et al.. (2021). Acupuncture Treatment Reduced the Risk of Coronary Heart Disease in Patients with Depression: A Propensity-Score Matched Cohort Study. Neuropsychiatric Disease and Treatment. Volume 17. 2315–2325. 6 indexed citations
7.
Lam, Alan, et al.. (2021). Uterine leiomyoma is associated with the risk of developing endometriosis: A nationwide cohort study involving 156,195 women. PLoS ONE. 16(8). e0256772–e0256772. 13 indexed citations
8.
Cheng, Hsin‐Yi Kathy, Ji‐An Liang, Yao‐Ching Hung, et al.. (2021). Stereotactic body radiotherapy for pelvic boost in gynecological cancer patients with local recurrence or unsuitable for intracavitary brachytherapy. Taiwanese Journal of Obstetrics and Gynecology. 60(1). 111–118. 12 indexed citations
9.
Chang, Cherry Yin‐Yi, et al.. (2021). Association of pelvic inflammatory disease (PID) with ovarian cancer: a nationwide population-based retrospective cohort study from Taiwan. BMC Women s Health. 21(1). 274–274. 4 indexed citations
10.
Wu, Mei‐Yao, et al.. (2021). Coprescription Trends in Western Medicine, Chinese Herbal Medicine and Dental Medicine among Older Adults in Taiwan from 1997 to 2013. Complementary Therapies in Medicine. 63. 102782–102782. 6 indexed citations
11.
Wang, Chieh, Mei‐Yao Wu, Cheng‐Li Lin, et al.. (2021). Adjunctive Chinese Herbal Medicine Treatment is Associated With an Improved Survival Rate in Patients With Cervical Cancer in Taiwan: A Matched Cohort Study. Integrative Cancer Therapies. 20. 1543376888–1543376888. 8 indexed citations
12.
Chang, Cherry Yin‐Yi, et al.. (2020). Association between oophorectomy and depression in patients with comorbidities: A nationwide cohort study in Taiwan. Taiwanese Journal of Obstetrics and Gynecology. 59(6). 899–905. 9 indexed citations
13.
Chang, Cherry Yin‐Yi, et al.. (2020). Increased risk of endometriosis in patients with endometritis — a nationwide cohort study involving 84,150 individuals. Ginekologia Polska. 91(4). 193–200. 3 indexed citations
14.
Chen, Shang-Wen, Ji‐An Liang, Yao‐Ching Hung, et al.. (2019). Effectiveness of Image-guided Brachytherapy in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy. Anticancer Research. 39(6). 3015–3024. 8 indexed citations
15.
Lin, Ying‐Chun, Ruiyun Chen, Ji‐An Liang, et al.. (2019). Immunohistochemical Biomarkers of Survival in Patients With Adenocarcinoma of the Uterine Cervix Receiving Chemoradiotherapy. Anticancer Research. 39(6). 3231–3240. 4 indexed citations
16.
Chen, Shang-Wen, Wei-Chih Shen, Te‐Chun Hsieh, et al.. (2018). Textural features of cervical cancers on FDG-PET/CT associate with survival and local relapse in patients treated with definitive chemoradiotherapy. Scientific Reports. 8(1). 11859–11859. 31 indexed citations
18.
Chiang, Jen‐Huai, et al.. (2018). Association of Pelvic Inflammatory Disease with Risk of Endometriosis: A Nationwide Cohort Study Involving 141,460 Individuals. Journal of Clinical Medicine. 7(11). 379–379. 61 indexed citations
19.
Lu, Chien‐Hsing, Yi‐Jen Chen, Kung‐Liahng Wang, et al.. (2014). Primary Treatment and Prognostic Factors of Carcinosarcoma of the Ovary, Fallopian Tube, and Peritoneum. International Journal of Gynecological Cancer. 24(3). 505–511. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026